Delcath Systems, Inc.
(NASDAQ : DCTH)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. 0.18%494.921.0%$1074.48m
ABTAbbott Laboratories 2.09%113.160.8%$979.30m
DHRDanaher Corp. -0.64%266.730.7%$823.29m
MDTMedtronic Plc 0.47%125.450.6%$625.75m
ISRGIntuitive Surgical, Inc. 0.01%905.492.3%$456.09m
BDXBecton, Dickinson & Co. 0.23%240.781.0%$384.71m
ALGNAlign Technology, Inc. 3.04%624.266.3%$313.45m
DXCMDexCom, Inc. -0.81%428.227.8%$304.41m
SYKStryker Corp. -0.37%261.671.3%$292.07m
BSXBoston Scientific Corp. 0.25%43.901.0%$278.00m
EWEdwards Lifesciences Corp. -0.58%104.150.4%$239.23m
BAXBaxter International, Inc. 0.57%81.391.8%$239.09m
ZBHZimmer Biomet Holdings, Inc. -0.36%163.881.7%$235.50m
AAgilent Technologies, Inc. -0.30%146.811.6%$234.94m
IDXXIDEXX Laboratories, Inc. -1.28%608.013.8%$213.25m

Company Profile

Delcath Systems, Inc. is an oncology company, which focuses on the treatment of primary and metastatic liver cancers. It develops and commercializes CHEMOSAT and Melphalan Hydrochloride for Injection, which is a proprietary product used with the Delcath Hepatic Delivery System. The company was founded in August 1988 and is headquartered in New York, NY.